ArticleClinical and experimental gastroenterology2019

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial.

Apichet Sirinawasatien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.